Adherence to therapy, lifestyle modification and medical support of cardiovascular patients
Open Access
- 31 December 2020
- journal article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 19 (6), 2665
- https://doi.org/10.15829/1728-8800-2020-2665
Abstract
Aim. To study the quantitative parameters of adherence to lifestyle modification, medical support, and therapy in patients with cardiovascular diseases (CVD).Material and methods. This cross-sectional study included 683 respondents: 168 patients with hypertension (HTN); 196 patients with stable angina; 141 patients with atrial fibrillation (AF); 178 patients with heart failure (HF). We used N. A. Nikolaev questionnaire for adherence assessment. For all adherence parameters, the level ≤75% was regarded as insufficient. The study was carried out in accordance with Good Clinical Practice and Declaration ofHelsinki. The study protocol was approved by the Ethics Committees of all participating clinical centers. All patients signed written informed consent.Results. Approximately 1/3 of respondents agreed to receive therapy. The adherence level was >75%. Patients with angina and AF were more likely to receive therapy. It turned out that that approximately 2/3 of patients were not ready for medical support. Patients with angina were less ready for medical support, while those with HTN and HF hadhigher values of adherence. Adherence to lifestyle modification was owest among analyzed parameters. Only 18,5% of hypertensive patients, 25,5% of patients with angina, 26,2% of AF patients and 23,1% of patients with HF were ready to change the lifestyle.Conclusion. The study revealed a significant number (~2/3) of CVD patients with insufficient adherence, which specifies the need to assess the effectiveness of therapy and course of the disease in conditions of low adherence and to develop individualized therapeutic strategies.Keywords
This publication has 10 references indexed in Scilit:
- Questionnaires and scores for assessing medication adherence — advantages and disadvantages of the diagnostic method in research and actual clinical practiceCardiovascular Therapy and Prevention, 2020
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromesEuropean Heart Journal, 2019
- The First Russian consensus on the quantitative assessment of the adherence to treatment (Approved by the XII National Congress of physicians - Moscow, 22–24 November 2017)Therapy, 2018
- 2018 ESC/ESH Guidelines for the management of arterial hypertensionEuropean Heart Journal, 2018
- The first russian expert consensus on the quantitative evaluation of the treatment adherence: pivotal issues, algorithms and recommendationsMedical news of the North Caucasus, 2018
- Accuracy of a screening tool for medication adherence: A systematic review and meta-analysis of the Morisky Medication Adherence Scale-8PLOS ONE, 2017
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTSEuropean Heart Journal, 2016
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Heart Journal, 2016
- Retracted: Predictive Validity of a Medication Adherence Measure in an Outpatient SettingThe Journal of Clinical Hypertension, 2008
- Concurrent and Predictive Validity of a Self-reported Measure of Medication AdherenceMedical Care, 1986